Literature DB >> 22963882

Number of CAG repeats in POLG1 and its association with Parkinson disease in the Norwegian population.

Novin Balafkan1, Charalampos Tzoulis, Bernd Müller, Kristoffer Haugarvoll, Ole-Bjørn Tysnes, Jan Petter Larsen, Laurence A Bindoff.   

Abstract

The number of CAG repeats in the mitochondrial DNA-polymerase gamma (POLG1) gene has been associated with Parkinson disease (PD) in some populations. We sequenced the CAG tract of POLG1 in 191 Norwegian patients with PD and an equal number of controls and found an association between non-10 or 11 CAG repeats and PD in our population. While our results were significant, this trend was not maintained following correction for multiple testing. We also performed a meta-analysis of all published studies including our own that shows PD is associated with the number of CAG repeats in POLG1. The meta-analysis reveals that the rare allelic variation encompassed by non-10 CAG repeats associates significantly with PD (p=0.0017). Whether this reflects a direct influence of POLG on the pathogenesis of PD or linkage disequilibrium between POLG1 alleles and nearby, disease-influencing genetic variants remains unknown.
Copyright © 2012 Elsevier B.V. and Mitochondria Research Society. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 22963882     DOI: 10.1016/j.mito.2012.08.004

Source DB:  PubMed          Journal:  Mitochondrion        ISSN: 1567-7249            Impact factor:   4.160


  9 in total

Review 1.  Targeting Mitochondria as a Therapeutic Approach for Parkinson's Disease.

Authors:  Maryam Abrishamdar; Maryam Sadat Jalali; Yaghoob Farbood
Journal:  Cell Mol Neurobiol       Date:  2022-08-11       Impact factor: 4.231

2.  Genetic risk factors in Finnish patients with Parkinson's disease.

Authors:  Susanna Ylönen; Ari Siitonen; Michael A Nalls; Pauli Ylikotila; Jaana Autere; Johanna Eerola-Rautio; Raphael Gibbs; Mikko Hiltunen; Pentti J Tienari; Hilkka Soininen; Andrew B Singleton; Kari Majamaa
Journal:  Parkinsonism Relat Disord       Date:  2017-09-29       Impact factor: 4.891

Review 3.  The Role of Mitochondria in Neurodegenerative Diseases: the Lesson from Alzheimer's Disease and Parkinson's Disease.

Authors:  Giacomo Monzio Compagnoni; Alessio Di Fonzo; Stefania Corti; Giacomo P Comi; Nereo Bresolin; Eliezer Masliah
Journal:  Mol Neurobiol       Date:  2020-05-22       Impact factor: 5.682

Review 4.  Ageing and Parkinson's disease: why is advancing age the biggest risk factor?

Authors:  Amy Reeve; Eve Simcox; Doug Turnbull
Journal:  Ageing Res Rev       Date:  2014-02-03       Impact factor: 10.895

5.  Molecular pathogenesis of polymerase γ-related neurodegeneration.

Authors:  Charalampos Tzoulis; Gia Tuong Tran; Jonathan Coxhead; Bjørn Bertelsen; Peer K Lilleng; Novin Balafkan; Brendan Payne; Hrvoje Miletic; Patrick F Chinnery; Laurence A Bindoff
Journal:  Ann Neurol       Date:  2014-06-14       Impact factor: 10.422

Review 6.  A genome on shaky ground: exploring the impact of mitochondrial DNA integrity on Parkinson's disease by highlighting the use of cybrid models.

Authors:  Martin Lang; Anne Grünewald; Peter P Pramstaller; Andrew A Hicks; Irene Pichler
Journal:  Cell Mol Life Sci       Date:  2022-05-05       Impact factor: 9.207

7.  The impact of mitochondrial DNA and nuclear genes related to mitochondrial functioning on the risk of Parkinson's disease.

Authors:  Katarzyna Gaweda-Walerych; Cezary Zekanowski
Journal:  Curr Genomics       Date:  2013-12       Impact factor: 2.236

Review 8.  Brain Mitochondria, Aging, and Parkinson's Disease.

Authors:  Mario Rango; Nereo Bresolin
Journal:  Genes (Basel)       Date:  2018-05-11       Impact factor: 4.096

9.  Rare genetic variation in mitochondrial pathways influences the risk for Parkinson's disease.

Authors:  Johannes J Gaare; Gonzalo S Nido; Paweł Sztromwasser; Per M Knappskog; Olav Dahl; Morten Lund-Johansen; Jodi Maple-Grødem; Guido Alves; Ole-Bjørn Tysnes; Stefan Johansson; Kristoffer Haugarvoll; Charalampos Tzoulis
Journal:  Mov Disord       Date:  2018-09-05       Impact factor: 10.338

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.